Literature DB >> 26835071

Inherited Arrhythmias - Where do we Stand?

Demosthenes G Katritsis1, Bernard J Gersh2, A John Camm3.   

Abstract

This review discusses inherited arrhythmias and conduction disturbances due to genetic disorders. Known channel mutations that are responsible for these conditions are presented, the indications and value of genetic testing are discussed, and a glossary of terms related to the discipline of genetic cardiology has been compiled.

Entities:  

Keywords:  Inherited arrhythmias; conduction disturbances; genetic channelopathies; mutations

Year:  2014        PMID： 26835071      PMCID： PMC4711494          DOI： 10.15420/aer.2014.3.2.80

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


  9 in total

1.  Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association.

Authors:  Santhi K Ganesh; Donna K Arnett; Themistocles L Assimes; Thermistocles L Assimes; Craig T Basson; Aravinda Chakravarti; Patrick T Ellinor; Mary B Engler; Elizabeth Goldmuntz; David M Herrington; Ray E Hershberger; Yuling Hong; Julie A Johnson; Steven J Kittner; Deborah A McDermott; James F Meschia; Luisa Mestroni; Christopher J O'Donnell; Bruce M Psaty; Ramachandran S Vasan; Marc Ruel; Win-Kuang Shen; Andre Terzic; Scott A Waldman
Journal:  Circulation       Date:  2013-12-02       Impact factor: 29.690

2.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

Authors:  Michael J Ackerman; Silvia G Priori; Stephan Willems; Charles Berul; Ramon Brugada; Hugh Calkins; A John Camm; Patrick T Ellinor; Michael Gollob; Robert Hamilton; Ray E Hershberger; Daniel P Judge; Hervè Le Marec; William J McKenna; Eric Schulze-Bahr; Chris Semsarian; Jeffrey A Towbin; Hugh Watkins; Arthur Wilde; Christian Wolpert; Douglas P Zipes
Journal:  Europace       Date:  2011-08       Impact factor: 5.214

Review 3.  Catecholaminergic polymorphic ventricular tachycardia.

Authors:  Antoine Leenhardt; Isabelle Denjoy; Pascale Guicheney
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-09-27

4.  Clinical interpretation and implications of whole-genome sequencing.

Authors:  Frederick E Dewey; Megan E Grove; Cuiping Pan; Benjamin A Goldstein; Jonathan A Bernstein; Hassan Chaib; Jason D Merker; Rachel L Goldfeder; Gregory M Enns; Sean P David; Neda Pakdaman; Kelly E Ormond; Colleen Caleshu; Kerry Kingham; Teri E Klein; Michelle Whirl-Carrillo; Kenneth Sakamoto; Matthew T Wheeler; Atul J Butte; James M Ford; Linda Boxer; John P A Ioannidis; Alan C Yeung; Russ B Altman; Themistocles L Assimes; Michael Snyder; Euan A Ashley; Thomas Quertermous
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

5.  Population-based variation in cardiomyopathy genes.

Authors:  Jessica R Golbus; Megan J Puckelwartz; John P Fahrenbach; Lisa M Dellefave-Castillo; Don Wolfgeher; Elizabeth M McNally
Journal:  Circ Cardiovasc Genet       Date:  2012-07-04

Review 6.  Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Authors:  David J Tester; Michael J Ackerman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 29.690

7.  DNA sequencing: clinical applications of new DNA sequencing technologies.

Authors:  Frederick E Dewey; Stephen Pan; Matthew T Wheeler; Stephen R Quake; Euan A Ashley
Journal:  Circulation       Date:  2012-02-21       Impact factor: 29.690

Review 8.  Genomics in cardiovascular disease.

Authors:  Robert Roberts; A J Marian; Sonny Dandona; Alexandre F R Stewart
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

Review 9.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.